Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ACC-789 (NVP-ACC789 (ZK202650); ZK-202650) is an effective, specific and orally active inhibitor of the VEGF receptor tyrosine kinases.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 39.00 | |
10 mg | In stock | $ 64.00 | |
25 mg | In stock | $ 88.00 | |
50 mg | In stock | $ 155.00 | |
100 mg | In stock | $ 228.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 43.00 |
Description | ACC-789 (NVP-ACC789 (ZK202650); ZK-202650) is an effective, specific and orally active inhibitor of the VEGF receptor tyrosine kinases. |
Targets&IC50 | VEGFR1 (human):0.38μM, PDGFRβ:1.4 μM, VEGFR3:0.18μM, VEGFR2 (mouse):0.23μM, VEGFR2 (human):0.02μM |
Synonyms | ACC-789, ZK202650 |
Molecular Weight | 405.29 |
Formula | C21H17BrN4 |
CAS No. | 300842-64-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 60 mg/mL (148.04 mM), Sonification and heating are recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
NVP-ACC789 300842-64-2 Angiogenesis Tyrosine Kinase/Adaptors PDGFR VEGFR ACC-789 NVP ACC789 Platelet-derived growth factor receptor inhibit NVPACC789 Inhibitor NVP-ACC-789 ACC 789 Vascular endothelial growth factor receptor ZK 202650 ACC789 ZK-202650 ZK202650 NVP-ACC 789 inhibitor